Literature DB >> 11695948

Linkage of bipolar disorder to chromosome 18q and the validity of bipolar II disorder.

F J McMahon1, S G Simpson, M G McInnis, J A Badner, D F MacKinnon, J R DePaulo.   

Abstract

BACKGROUND: An analysis of the relationship between clinical features and allele sharing could clarify the issue of genetic linkage between bipolar affective disorder (BPAD) and chromosome 18q, contributing to the definition of genetically valid clinical subtypes.
METHODS: Relatives ascertained through a proband who had bipolar I disorder (BPI) were interviewed by a psychiatrist, assigned an all-sources diagnosis, and genotyped with 32 markers on 18q21-23. Exploratory findings from the first 28 families (n = 247) were tested prospectively in an additional 30 families (n = 259), and the effect of confirmed findings on the linkage evidence was assessed.
RESULTS: In exploratory analyses, paternal allele sharing on 18q21 was significantly (P =.03) associated with a diagnostic subtype, and was greatest in pairs where both siblings had bipolar II disorder (BPII). Prospective analysis confirmed the finding that BPII-BPII sibling pairs showed significantly (P =.016) greater paternal allele sharing. Paternal allele sharing across 18q21-23 was also significantly greater in families with at least one BPII-BPII sibling pair. In these families, multipoint affected sibling-pair linkage analysis produced a peak paternal lod score of 4.67 (1-lod confidence interval, 12 centimorgans [cM]) vs 1.53 (1-lod confidence interval, 44 cM) in all families.
CONCLUSIONS: Affected sibling pairs with BPII discriminated between families who showed evidence of linkage to 18q, and families who did not. Families with a BPII sibling pair produced an increased lod score and improved linkage resolution. These findings, limited by the small number of BPII-BPII sibling pairs, strengthen the evidence of genetic linkage between BPAD and chromosome 18q, and provide preliminary support for BPII as a genetically valid subtype of BPAD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11695948     DOI: 10.1001/archpsyc.58.11.1025

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  13 in total

1.  Heritability and familiality of psychopathologic dimensions in Korean families with schizophrenia.

Authors:  Hwagyu Suh; Byung Dae Lee; Je Min Park; Young Min Lee; Eunsoo Moon; Hee Jeong Jeong; Soo Yeon Kim; Kang Yoon Lee; Young In Chung
Journal:  Psychiatry Clin Neurosci       Date:  2019-02-02       Impact factor: 5.188

Review 2.  Pharmacotherapy for the treatment of acute bipolar II depression: current evidence.

Authors:  Holly A Swartz; Michael E Thase
Journal:  J Clin Psychiatry       Date:  2010-08-10       Impact factor: 4.384

3.  Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families.

Authors:  M Daniele Fallin; Virginia K Lasseter; Paula S Wolyniec; John A McGrath; Gerald Nestadt; David Valle; Kung-Yee Liang; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

Review 4.  Current research in child and adolescent bipolar disorder.

Authors:  Christine A Demeter; Lisa D Townsend; Michael Wilson; Robert L Findling
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

5.  Neurotransmission and bipolar disorder: a systematic family-based association study.

Authors:  Jiajun Shi; Judith A Badner; Eiji Hattori; James B Potash; Virginia L Willour; Francis J McMahon; Elliot S Gershon; Chunyu Liu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

Review 6.  Genetics of bipolar disorder.

Authors:  Michael A Escamilla; Juan M Zavala
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

7.  Relationship between personality disorder functioning styles and the emotional states in bipolar I and II disorders.

Authors:  Jiashu Yao; You Xu; Yanhua Qin; Jing Liu; Yuedi Shen; Wei Wang; Wei Chen
Journal:  PLoS One       Date:  2015-01-27       Impact factor: 3.240

8.  Verbal and Visual Memory Impairments in Bipolar I and II Disorder.

Authors:  Tae Hyon Ha; Ji Sun Kim; Jae Seung Chang; Sung Hee Oh; Ju Young Her; Hyun Sang Cho; Tae Sung Park; Soon Young Shin; Kyooseob Ha
Journal:  Psychiatry Investig       Date:  2012-11-12       Impact factor: 2.505

9.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder.

Authors:  Ricardo Segurado; Sevilla D Detera-Wadleigh; Douglas F Levinson; Cathryn M Lewis; Michael Gill; John I Nurnberger; Nick Craddock; J Raymond DePaulo; Miron Baron; Elliot S Gershon; Jenny Ekholm; Sven Cichon; Gustavo Turecki; Stephan Claes; John R Kelsoe; Peter R Schofield; Renee F Badenhop; J Morissette; Hilary Coon; Douglas Blackwood; L Alison McInnes; Tatiana Foroud; Howard J Edenberg; Theodore Reich; John P Rice; Alison Goate; Melvin G McInnis; Francis J McMahon; Judith A Badner; Lynn R Goldin; Phil Bennett; Virginia L Willour; Peter P Zandi; Jianjun Liu; Conrad Gilliam; Suh-Hang Juo; Wade H Berrettini; Takeo Yoshikawa; Leena Peltonen; Jouko Lönnqvist; Markus M Nöthen; Johannes Schumacher; Christine Windemuth; Marcella Rietschel; Peter Propping; Wolfgang Maier; Martin Alda; Paul Grof; Guy A Rouleau; Jurgen Del-Favero; Christine Van Broeckhoven; Julien Mendlewicz; Rolf Adolfsson; M Anne Spence; Hermann Luebbert; Linda J Adams; Jennifer A Donald; Philip B Mitchell; Nicholas Barden; Eric Shink; William Byerley; Walter Muir; Peter M Visscher; Stuart Macgregor; Hugh Gurling; Gursharan Kalsi; Andrew McQuillin; Michael A Escamilla; Victor I Reus; Pedro Leon; Nelson B Freimer; Henrik Ewald; Torben A Kruse; Ole Mors; Uppala Radhakrishna; Jean-Louis Blouin; Stylianos E Antonarakis; Nurten Akarsu
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

10.  Heritability and Familiality of Temperament and Character Dimensions in Korean Families with Schizophrenic Linkage Disequilibrium.

Authors:  Byung Dae Lee; Je Min Park; Young Min Lee; Eunsoo Moon; Hee Jeong Jeong; Young In Chung; Young Mi Yi
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.